MX9703975A - Nueva formulacion antitrombotica, proceso para su fabricacion y uso de la misma. - Google Patents
Nueva formulacion antitrombotica, proceso para su fabricacion y uso de la misma.Info
- Publication number
- MX9703975A MX9703975A MX9703975A MX9703975A MX9703975A MX 9703975 A MX9703975 A MX 9703975A MX 9703975 A MX9703975 A MX 9703975A MX 9703975 A MX9703975 A MX 9703975A MX 9703975 A MX9703975 A MX 9703975A
- Authority
- MX
- Mexico
- Prior art keywords
- formulation
- manufacturing
- new antithrombotic
- thromboembolism
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Se proporciona una nueva formulacion farmacéutica que comprende el inhibidor de trombina HOOC-CH2-(R)-Cgl-Aze-Pab en combinacion con uno o más agentes mejoradores de absorcion, un proceso para la preparacion de tal formulacion farmacéutica, el uso de tal formulacion en el tratamiento de tromboembolia así como para tratar a un paciente en necesidad de tratamiento antitrombotico y tromboembolia mediante la utilizacion de la formulacion.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9404196-9 | 1994-12-02 | ||
| SE9404196A SE9404196D0 (sv) | 1994-12-02 | 1994-12-02 | New antithrombotic formulation |
| PCT/SE1995/001425 WO1996016671A1 (en) | 1994-12-02 | 1995-11-29 | New antithrombotic formulation, process for its manufacturing, and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9703975A true MX9703975A (es) | 1997-09-30 |
| MXPA97003975A MXPA97003975A (es) | 1998-07-03 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9510242B (en) | 1996-06-03 |
| FI972332A (fi) | 1997-06-02 |
| US5795896A (en) | 1998-08-18 |
| NO972475L (no) | 1997-05-30 |
| FI972332A0 (fi) | 1997-06-02 |
| WO1996016671A1 (en) | 1996-06-06 |
| EE03338B1 (et) | 2001-02-15 |
| EP0799052A1 (en) | 1997-10-08 |
| CZ147097A3 (cs) | 1998-02-18 |
| AU4191596A (en) | 1996-06-19 |
| HU216631B (hu) | 1999-07-28 |
| PT799052E (pt) | 2002-05-31 |
| DE69523943D1 (de) | 2001-12-20 |
| IS4483A (is) | 1997-05-16 |
| JPH10513438A (ja) | 1998-12-22 |
| AR002254A1 (es) | 1998-03-11 |
| EP0799052B1 (en) | 2001-11-14 |
| HUT77655A (hu) | 1998-07-28 |
| IL116153A0 (en) | 1996-01-31 |
| NZ297118A (en) | 1998-12-23 |
| DK0799052T3 (da) | 2002-02-25 |
| PL320692A1 (en) | 1997-10-27 |
| BR9509853A (pt) | 1997-12-30 |
| ES2168395T3 (es) | 2002-06-16 |
| ATE208628T1 (de) | 2001-11-15 |
| SE9404196D0 (sv) | 1994-12-02 |
| CA2206459A1 (en) | 1996-06-06 |
| CN1168635A (zh) | 1997-12-24 |
| SK61797A3 (en) | 1998-03-04 |
| IL116153A (en) | 1999-11-30 |
| NO972475D0 (no) | 1997-05-30 |
| TR199501517A2 (tr) | 1996-07-21 |
| AU689994B2 (en) | 1998-04-09 |
| DE69523943T2 (de) | 2002-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9404196D0 (sv) | New antithrombotic formulation | |
| UA32429C2 (uk) | Засіб для лікування нетримання сечі | |
| MX9700538A (es) | Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares. | |
| ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| GR3019514T3 (en) | Pharmaceutical preparation for the treatment of prolonged coagulation time | |
| MY138883A (en) | Use of asiatic acid for treatment of cencer | |
| GB9305718D0 (en) | Medicaments | |
| KR950700726A (ko) | 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use) | |
| HU9201799D0 (en) | New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments | |
| ZA849576B (en) | 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases | |
| SE9602145D0 (sv) | New improved formulation for treatment of thromboembolism | |
| ES2190581T3 (es) | 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico. | |
| NO970185L (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
| EP0458537A3 (en) | Therapeutic compound for the treatment of bronchitis | |
| RU96119673A (ru) | Способ лечения болевого синдрома | |
| ES2044534T3 (es) | Un metodo para la preparacion de una composicion tromboliticamente activa. | |
| AUPR916101A0 (en) | Method of treating halitosis | |
| PT1313500E (pt) | Associacoes de dalfopristina/quinupristina com o cefpirome | |
| NO984190L (no) | FremgangsmÕte for behandling av insomnia | |
| UA36485A (uk) | Спосіб лікування генералізованого пародонтиту | |
| UA33439A (uk) | Спосіб інтенсивного лікування шизофренії | |
| UA33531A (uk) | Спосіб терапії шизофренії | |
| RU92015326A (ru) | Средство для лечения конъюнктивита | |
| UA15363A (uk) | Засіб для лікуваhhя відкритих пошкоджеhь |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |